XBiotech Inc.
XBIT
$2.32
-$0.09-3.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -242.14% | 83.87% | -3.58% | -109.53% | 61.44% |
| Total Depreciation and Amortization | -2.73% | -0.68% | 0.68% | 0.00% | 0.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 141.22% | -197.67% | -35.60% | 1,482.46% | -136.66% |
| Change in Net Operating Assets | 105.65% | -350.81% | 156.46% | -29.34% | -453.82% |
| Cash from Operations | 28.89% | 10.88% | -2.75% | -11.89% | 48.62% |
| Capital Expenditure | -115.69% | 45.74% | -11.90% | 75.15% | 46.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -115.69% | 45.74% | -11.90% | 75.15% | 46.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -48.44% | 33.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -3,721.91% | 342.19% | 33.33% |
| Foreign Exchange rate Adjustments | -139.01% | 984.86% | 106.93% | -679.92% | 227.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.27% | 82.37% | -60.71% | -92.92% | 56.74% |